Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-06-24

Clinical Trial Update: The Opioid-sparing Effect and Reduced PONV Using Propacetamol in PCA Among Patients With High Risk of PONV [NA]

View source ↗

Summary

Completed clinical trial evaluating whether adding propacetamol to patient-controlled analgesia reduces opioid use in patients at high risk for postoperative na…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Propacetamol (propacetamol)

Snippet

Sponsor: Yonsei University | Conditions: PONV, Propacetamol | NA | Status: COMPLETED